NCT02600988View on ClinicalTrials.gov

Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Hematopoietic Stem Cell Transplantation
Interventions
DRUG

1000IU/day of Vitamine D

Administration of a specified dose of Vitamine D

DRUG

5000IU/day of Vitamine D

Administration of a specified dose of Vitamine D

Trial Locations (7)

Unknown

Christelle Ferrà i Coll, Badalona

Carmen Martínez, Barcelona

David Valcárcel Ferreiras, Barcelona

Raquel Saldaña Moreno, Jerez de la Frontera

Manuel Jurado Chacón, Granada

Mª Ángeles Cuesta, Málaga

Fermín Martín Sánchez- Guijo, Salamanca

All Listed Sponsors
lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT02600988 - Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant | Biotech Hunter | Biotech Hunter